The FDA Sept. 29 released a long-anticipated proposed rule under which the agency’s regulations would specify that laboratory developed tests (LDTs) are to be regulated as medical devices. In addition, the FDA proposed a phaseout period for the enforcement discretion that the agency has exercised for years with respect to the tests. The proposed rule — the latest step in the... Read More